Share this article
Share this article
AUSTIN, Texas, March 9, 2021 /PRNewswire/ Clay A. Cauthen, MD, MA, is being recognized by Continental Who s Who as a Top Doctor in the field of Medicine for his professional excellence as a Transplant Cardiologist/Program Director for the Cardiology Fellowship Program with the Seton Heart Institute – Medical Park Tower/University of Texas Austin.
Leading an outstanding medical career for 15 years, Dr. Cauthen has garnered a well-deserving reputation for his professional excellence. He is a board-certified and fellowship-trained Transplant Cardiologist, currently serving patients at Seton Heart Institute – Medical Park Tower in Austin, Texas for the past seven years. He examines and treats patients with congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology. Dedicated to keeping his patients well-informed, he also advises on the best course of action for his patients, spending time,
email article
An international committee proposed a universal definition for heart failure (HF) and two standard classifications that go beyond reduced and preserved left ventricular ejection fraction (LVEF). HF is a clinical syndrome with symptoms and or signs caused by a structural and or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and or objective evidence of pulmonary or systemic congestion, according to the consensus document from the Heart Failure Society of America (HFSA), European Society of Cardiology, and Japanese Heart Failure Society.
This is a slight difference from the definition of HF from the American College of Cardiology (ACC) and American Heart Association: a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood.
email article
After the all-male (and largely white) faculty lineup at the Heart Failure 2021 virtual meeting from Los Angeles drew ire on Twitter, organizers made swift changes.
Both program directors and all 23 speakers originally scheduled to lecture at the small subspecialty symposium March 12-13 are men. Gentleman, it s 2021 and there are soooooo many women in heart failure for this entire conference to be all men. Do better, Nasrien E. Ibrahim, MD, of Massachusetts General Hospital in Boston, tweeted on Wednesday with pictures of the then-current faculty list.
Ironically, Wednesday was also National Women Physicians Day.
Ibrahim called out the organizers for lack of effort, writing you didn t search hard enough. Others weren t so generous.
Jan 12, 2021
Consistent benefit regardless of CKD etiology
Once, in the not-too-distant past, one could not scan the latest issue of any top-tier medical journal without finding at least one trial extolling the benefits of statin therapy, which lead many to suggest and not always facetiously that it was time to add statins to the water.
Since late summer 2019 when the results of DAPA-HF were reported at the 2019 European Society of Cardiology Congress in Paris, SGLT2 inhibitors have displaced statins as the pharmaceutical of choice for those who like the “one-drug-fits-all-conditions” approach to the art of medicine.
The latest entry comes from David C. Wheeler, MB, ChB, MD of the George Institute for Global Health in Sydney, Australia, who with his co-investigators offers another look at the findings from DAPA-CKD in
email article
A certain number of heart attacks, strokes, and other unrelated incidents soon after vaccination are to be expected statistically, but how can those anecdotes avoid becoming anti-vaccine fodder? (
STAT)
Maintaining oral anticoagulation through transcatheter aortic valve replacement actually was associated with fewer transfusions and no more bleeding or vascular complications in a large European series. (
JACC: Cardiovascular Interventions)
Lower superficial temporal artery access for coronary angiography and interventions is feasible in COVID-19 patients when standard sites aren t readily accessible. (
European Heart Journal Case Reports)
The University of Florida basketball player who collapsed on the court during a game earlier this month was diagnosed with acute myocarditis potentially linked to COVID-19 infection over the summer. (